Purification and characterization of konjac
glucomannan degrading enzyme from anaerobic human intestinal bacterium,
Clostridium butyricum-Clostridium beijerinckii group.
Efficacy of rifaximin in the treatment of
symptomatic diverticular disease of the colon. A multicentre double-blind
Use of glucomannan dietary fiber in changes
in intestinal habit
Efficacy of rifaximin on symptoms of uncomplicated
diverticular disease of the colon. A pilot multicentre open trial.
Diverticular Disease Study Group.